<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(8)</volume><submitter>Zeng Y</submitter><pubmed_abstract>Preparation and characterization of a series of oligo(ethylene glycol)methylether functionalized alkynyl gold(i) complexes capped with AuPPh&lt;sub>3&lt;/sub> (1a-1d) or dppfAu&lt;sub>2&lt;/sub> (dppf, 1,1'-&lt;i>bis&lt;/i>(diphenyphosphino)ferrocene) (2a-2d) have been accomplished. The structures of 1b and 1c were established by X-ray crystallography. Their &lt;i>in vitro&lt;/i> antitumor activities were measured by the CCK8 method against A549 and HeLa cells. The studies indicated that the cytotoxic activity &lt;i>in vitro&lt;/i> was fine-tuned by modification of both the gold(i) centers and the oligo(ethylene glycol)methylether ancillary ligands. Compared to the dppfAu&lt;sub>2&lt;/sub> series, the AuPPh&lt;sub>3&lt;/sub> series showed better cytotoxicity. Especially, complex 4-(OCH&lt;sub>2&lt;/sub>CH&lt;sub>2&lt;/sub>OCH&lt;sub>2&lt;/sub>CH&lt;su</pubmed_abstract><journal>RSC advances</journal><pagination>7092-7096</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12865784</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis and antitumor activity of mono and digold(i) alkynyl complexes with oligo(ethylene glycol)methylether.</pubmed_title><pmcid>PMC12865784</pmcid><pubmed_authors>Chen QM</pubmed_authors><pubmed_authors>Zhou P</pubmed_authors><pubmed_authors>Zhang JF</pubmed_authors><pubmed_authors>Ren WX</pubmed_authors><pubmed_authors>Mou X</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Zheng F</pubmed_authors><pubmed_authors>Wu XH</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and antitumor activity of mono and digold(i) alkynyl complexes with oligo(ethylene glycol)methylether.</name><description>Preparation and characterization of a series of oligo(ethylene glycol)methylether functionalized alkynyl gold(i) complexes capped with AuPPh&lt;sub>3&lt;/sub> (1a-1d) or dppfAu&lt;sub>2&lt;/sub> (dppf, 1,1'-&lt;i>bis&lt;/i>(diphenyphosphino)ferrocene) (2a-2d) have been accomplished. The structures of 1b and 1c were established by X-ray crystallography. Their &lt;i>in vitro&lt;/i> antitumor activities were measured by the CCK8 method against A549 and HeLa cells. The studies indicated that the cytotoxic activity &lt;i>in vitro&lt;/i> was fine-tuned by modification of both the gold(i) centers and the oligo(ethylene glycol)methylether ancillary ligands. Compared to the dppfAu&lt;sub>2&lt;/sub> series, the AuPPh&lt;sub>3&lt;/sub> series showed better cytotoxicity. Especially, complex 4-(OCH&lt;sub>2&lt;/sub>CH&lt;sub>2&lt;/sub>OCH&lt;sub>2&lt;/sub>CH&lt;su</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T06:43:09.932Z</modification><creation>2026-06-30T03:21:57.987Z</creation></dates><accession>S-EPMC12865784</accession><cross_references><pubmed>41641232</pubmed><doi>10.1039/d5ra08951d</doi></cross_references></HashMap>